News Focus
News Focus
icon url

DewDiligence

05/06/15 9:32 AM

#190889 RE: DewDiligence #190058

ABBV’s Venetoclax (f/k/a ABT-199) gets BTD in second-line CLL with 17p-deletion:

http://finance.yahoo.com/news/investigational-medicine-venetoclax-receives-breakthrough-113000749.html